The first hospitalization after recovery from COVID-19 and its relationship with Remdesivir treatment: Short Communication

With the emergence of Corona disease in late 2019, the healthcare network was directly and indirectly affected, and the process and management of patients other than COVID-19 changed. To evaluate some of these changes, the present study was conducted on post-COVID-19 hospital admissions of patients who have been infected with Coronavirus in the past. The census method was used for patients’ recruitment. The collected data was analyzed using descriptive/analytical statistical methods. A total of 202 patients with a mean age of (57.60±18.73) years, including 109 (54%) women and 93 (46%) men, were recruited. The number and percentage of cases admitted in internal, infectious, neurology, and heart wards, were 63 (31%), 52 (25.7%), 35 (17.3%), and 31 (15.3%), respectively. No correlation was found between the history of hospitalization and the type of treatment specific to COVID-19 (Remdesivir) and the disease that led to re-hospitalization after recovery from COVID-19 (P=0.08). Regardless of whether receiving Remdesivir or not, post-COVID-19 hospitalization due to various reasons in internal and infectious wards was the most frequent, respectively, followed by cardiovascular events.